108899 ⎘
Enzymes; Proenzymes; Compositions thereof ; Processes for preparing, activating, inhibiting, separating or purifying enzymes; Transferases (2.); Acyltransferases (2.3) Aminoacyltransferases (2.3.2)
Sub-classes:MODULATION OF PROTEIN DEGRADATION
#2ELECTRO-BIODIESEL EMPOWERED BY CO-DESIGN OF MICROORGANISM AND ELECTROCATALYSIS
#3POLYPEPTIDE SEQUENCING REAGENTS AND METHODS OF USE
#4AAV GENE THERAPY FOR TREATING A NERVOUS SYSTEM DISEASE
#5GENERATION OF LOW-ARSENIC AND LOW-CADMIUM RICE
#6PROTEIN SCAFFOLDS FOR DISORDERED REGIONS
#7METHOD FOR PRODUCING USEFUL SUBSTANCE
#8METHOD FOR TREATING A PARKINSON'S DISEASE
#9METHOD OF SCREENING
#10METHODS OF CONTROLLING GRAIN SIZE
#11Improving the Efficiency of PAL-Catalyzed Protein Ligation By A Cascade Enzymatic Scheme
#12CHIMAERIC PROTEINS AND THERAPEUTIC AGENTS
#13IN SILICO METHOD OF IDENTIFYING ALLOSTERIC HECT E3-LIGASE INHIBITORS
#14FUSION PROTEINS COMPRISING AN E2 UBIQUITIN OR UBIQUITIN-LIKE CONJUGATING DOMAIN AND A TARGETING DOMAIN FOR SPECIFIC PROTEIN DEGRADATION
#15BETA-CATENIN PROTEIN DEGRADATION
#16METHOD OF GENERATING PULCHERRIMIN AND PULCHERRIMINIC ACID AND USES THEREOF
#17CHIMERA MOLECULES FOR SARS-COV-2 AND METHODS OF USE
#18COMPOUNDS AND METHODS FOR FBXO22-MEDIATED PROTEIN DEGRADATION
#19MOLECULES FOR ORGANELLE-SPECIFIC PROTEIN DELIVERY
#20BACTERIAL SYSTEMS FOR ANALYZING UBIQUITYLATED POLYPEPTIDES
#21PROTEIN DEGRADATION SYSTEM, COMPONENTS, AND METHODS
#22COMPOSITIONS AND METHODS FOR TREATING VIRAL INFECTIONS TARGETING TRIM7
#23POST-TRANSLATIONAL MODIFICATION CHIMERIC MOLECULE
#24COMPOSITIONS AND METHODS COMPRISING PLANTS WITH MODIFIED SEED PROTEIN AND/OR OIL CONTENT
#25IMPROVED CYTOSINE TO GUANINE BASE EDITORS
#26PROTEIN DEGRADATION
#27MOLECULES FOR ORGANELLE-SPECIFIC PROTEIN DELIVERY
#28Molecules for organelle-specific protein delivery
#29FUSION PROTEINS COMPRISING TWO RING DOMAINS
#30COMPOSITIONS AND METHODS FOR THE VECTORED AUGMENTATION OF PROTEIN DESTRUCTION, EXPRESSION AND/OR REGULATION
#31NOVEL GLUTAMINYL CYCLASE INHIBITORS AND THE USE THEREOF IN TREATMENT OF VARIOUS DISEASES
#32RIBOSOMAL RNA SCAFFOLDS FOR PROTEIN-FREE AND TEMPLATE-FREE SYNTHESIS OF PEPTIDES
#33TRANSGENIC PLANT WITH REDUCED HEAVY METALS AND METHODS FOR PREPARATION THEREOF
#34Oncolytic viruses targeting STAT3
#35ADP-RIBOSE BINDING PEPTIDES WITH ANTI-CANCER ACTIVITY AND USE THEREOF
#36WW-DOMAIN-ACTIVATED EXTRACELLULAR VESICLES
#37WW-DOMAIN-ACTIVATED EXTRACELLULAR VESICLES TARGETING CORONAVIRUSES
#38REPLACEMENT OF RAG1 FOR USE IN THERAPY
#39DOWNREGULATION OF MEMBRANE-BOUND PROTEINS BY RECEPTOR TAC TECHNOLOGY
#40COMPOSITIONS COMPRISING LINEAR POLYRIBONUCLEOTIDES FOR PROTEIN MODULATION AND USES THEREOF
#41MODIFIED UBE3A GENE FOR A GENE THERAPY APPROACH FOR ANGELMAN SYNDROME
#42ARTIFICIAL EUKARYOTIC EXPRESSION SYSTEM WITH ENHANCED PERFORMANCES
#43EXPRESSION SYSTEMS, RECOMBINANT CELLS AND USES THEREOF
#44Screening method for effective target - E3 ligase combinations
#45FULLY ORTHOGONAL SYSTEM FOR PROTEIN SYNTHISIS IN BACTERIAL CELLS
#46DETECTION OF NOVEL DEGRADATION-RELATED INTERACTIONS
#47ANTIGEN-BINDING AND ANTIGEN DEGRADATION CONSTRUCTS
#48MODULATION OF PROTEIN DEGRADATION
#49AUXIN-INDUCIBLE DEGRON SYSTEM KIT AND USE THEREOF
#50NONHUMAN ANIMAL AND USE FOR SAME
#51Compositions and methods for treating viral infections targeting TRIM7
#52UBE3A FOR THE TREATMENT OF ANGELMAN SYNDROME
#53SELECTIVE DEGRADATION OF PROTEINS
#54METHOD FOR PRODUCING USEFUL SUBSTANCE
#55ACTIVITY BASED PROBES
#56RIBOSOME VARIANTS FOR SEQUENCE DEFINED POLYMER SYNTHESIS
#57COMPOSITIONS FOR SUPPRESSING TRIM28 AND USES THEREOF
#58ONCOLYTIC VIRUSES TARGETING STAT3
#59ONCOLYTIC VIRUSES TARGETING STAT3
#60POLYPEPTIDE DIRECTED AGAINST PROTEIN TYROSINE PHOSPHATASE 4A PROTEINS, AND COMPOSITIONS AND METHODS FOR USE THEREOF
#61Breast and ovarian cancer vaccines
#62COMPOSITIONS AND METHODS FOR GENETICALLY-ENCODED HIGH VOLTAGE-ACTIVATED CALCIUM CHANNEL BLOCKERS USING ENGINEERED UBIQUITIN LIGASES
#63MINIMAL PEPTIDE FUSIONS FOR TARGETED INTRACELLULAR PROTEIN DEGRADATION
#64INFLAMMATION-ENABLING POLYPEPTIDES AND USES THEREOF
#65NOVEL GENE RELATED TO PLANT DROUGHT STRESS TOLERANCE AND USES THEREOF
#66METHODS OF INHIBITING PROLIFERATIVE CELLS
#67Salt-loving bacillus polyfermenticus strain for producing salt-tolerant gamma-glutamyl transpeptidase
#68Molecules for organelle-specific protein delivery
#69LINEAR POLYFUNCTIONAL MULTIMER BIOMOLECULE COUPLED TO POLYUBIQUITIN LINKER AND USE THEREOF
#70Breast and ovarian cancer vaccines
#71PROTEIN LABELLING
#72BACTERIAL SYSTEMS FOR ANALYZING UBIQUITYLATED POLYPEPTIDES
#73GENE THERAPY FOR CNS DEGENERATION
#74INTRACELLULAR DELIVERY OF TARGET-SILENCING PROTEIN
#75BROAD-SPECTRUM PROTEOME EDITING WITH AN ENGINEERED BACTERIAL UBIQUITIN LIGASE MIMIC
#76Cellular transport system for transferring a sulfonic acid construct carrying a cargo into the cytoplasm of a cell
#77UBIQUITIN VARIANT MODULATORS OF HECT E3 LIGASES AND THEIR USES
#78COMPOUNDS AND METHODS OF MODULATING PROTEIN DEGRADATION
#79Dough Relaxation Using Gamma Glutamyl Transpeptidase
#80PROTEIN EXPRESSION STRAINS
#81MICROORGANISMS PROGRAMMED TO PRODUCE IMMUNE MODULATORS AND ANTI-CANCER THERAPEUTICS IN TUMOR CELLS
#82Glutaminyl cyclase inhibitors and the use thereof in treatment of various diseases
#83Breast and ovarian cancer vaccines
#84Tunable endogenous protein degradation with heterobifunctional compounds
#85Compositions and methods comprising permuted protein tags for facilitating overexpression, solubility, and purification of target proteins
#86Production of citronellal and citronellol in recombinant hosts
#87Animal model of Angelman Syndrome
#88Peptides having effects of preventing or treating central nervous system diseases and pharmaceutical compositions for preventing or treating central nervous system diseases containing same as active ingredient
#89Bacterial systems for analyzing ubiquitylated polypeptides
#90MG53 mutants, methods of making the same, and uses thereof
#91Oncolytic viruses targeting STAT3
#92Designer ribosomes and methods of use thereof for incorporating non-standard amino acids into polypeptides
#93Method for producing metal nanoparticles and metal sulfide nanoparticles using a recombinant microorganism
#94Recombinant microorganism having ability to produce poly(lactate-coglycolate) or copolymer thereof from xylose and method for preparing poly(lactate-coglycolate) or copolymer thereof by using same
#95Probes and assays for measuring E3 ligase activity
#96METHODS OF TREATING CANCER
#97Photocrosslinking reagents and methods of use thereof
#98Modified UBE3A gene for a gene therapy approach for angelman syndrome
#99Transgenic plants exhibiting enhanced phytochelatin-based heavy metal tolerance and methods of use thereof
#100Ubiquitin variant modulators of HECT E3 ligases and their uses
#101TOBACCO PROTEASE GENES
#102MUTATIONS OF THE PARKIN GENE, COMPOSITIONS, METHODS AND USES
#103Breast and ovarian cancer vaccines
#104Method for producing gamma-glutamylvalylglycine or a salt thereof
#105Expression system for producing protein having a N-terminal pyroglutamate residue
#106Method for treating infections
#107Kidney disease biomarker
#108TRANSGENIC MOUSE EXPRESSING HUMAN ISOGLUTAMINYL CYCLOTRANSFERASE
#109Method for producing 3-acetylamino-4-hydroxybenzoic acid
#110Method for producing γ-glutamylvalylglycine or a salt thereof
#111Traceless Ubiquitination
#112Mouse models carrying a knock-out mutation of the QPCTL-gene
#113Methods of Identifying and Characterizing Natural Product Gene Clusters
#114Crystal structure of glutaminyl cyclase
#115Mutant microorganism having high production of cadaverine, and preparation method of cadaverine using same
#116IN VIVO SCREENING MODELS FOR TREATMENT OF QC-RELATED DISORDERS
#117Genetically programmed expression of proteins containing the unnatural amino acid phenylselenocysteine
#118TRANSGENIC PLANTS WITH ALTERED REDOX MECHANISMS AND INCREASED YIELD
#119Screening method for enzyme inhibitors
#120Crystal structure of isoglutaminyl cyclase
#121Mutants of and uses thereof
#122IN VIVO SCREENING MODELS FOR TREATMENT OF isoQC-RELATED DISORDERS
#123Mutations of the parkin gene
#124Crystal structure of glutaminyl cyclase
#125METHOD FOR THE RECOVERY OF DEGRADED AREAS USING GENETICALLY MODIFIED PLANT SPECIES
#126Method for producing L-amino acid
#127METHOD FOR IMPROVING SALINITY TOLERANCE
#128Method for preparing metal nanoparticle using metal binding protein
#129Protein refolding method
#130CYCLODIPEPTIDE SYNTHASES (CDSS) AND THEIR USE IN THE SYNTHESIS OF LINEAR DIPEPTIDES
#131Designer Ubiquitin Ligases For Regulation Of Intracellular Pathogenic Proteins
#132METHODS AND COMPOUNDS FOR FORMING MONOLITHIC TITANIA, OPTIONALLY BIOMOLECULE DOPED, WITH CONTROLLED MORPHOLOGY USING BIOCOMPATIBLE SOL-GEL PROCESSES
#133Use of isoQC inhibitors in the treatment and prevention of inflammatory diseases or conditions
#134FERRIC REDUCTASE ACTIVITY OF HISTOPLASMA CAPSULATUM Y-GLUTAMYLTRANSFERASE
#135Method for treating infections
#136Method of screening for inhibitors of glutaminyl cyclase activity
#137Genetically programmed expression of proteins containing the unnatural amino acid phenylselenocysteine
#138Crystal structure of soluble glutaminyl cyclase
#139Mouse carrying a knock-out mutation of the Qpct-gene
#140Process for the enzymatic preparation of a gamma-glutamyl compound
#141Transgenic mouse models of Aβ overexpression
#142In Vitro Reconstitution of Ribonucleoprotein Complexes, and Methods of Use Therefor
#143NOVEL GENES RELATED TO GLUTAMINYL CYCLASE
#144IN VIVO SCREENING MODELS FOR TREATMENT OF ALZHEIMER'S DISEASE AND OTHER QPCT-RELATED DISORDERS
#145Transmembrane domain removed recombinant human tyrosinase and method of producing the same
#146Express system of soluble glutaminyl cyclase
#147Genetically programmed expression of proteins containing the unnatural amino acid phenylselenocysteine
#148Crystal structure of soluble glutaminyl cyclase
#149Method of cross-linking peptides
#150Protein purification means
#151Detection system
#152Soluble recombinant protein production
#153Protein inducing cell death of helicobacter pylori
#154Streptococcus pneumoniae pbp2x mini-protein and uses thereof
#155Metal resistant plants and phytoremediation of environmental contamination
#156Bacterial phytochelatin synthetase
#157Identification of sortase gene
#158Selective degradation of proteins